{{Use mdy dates|date=October 2013}}
{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 464213174
| IUPAC_name = 4-[3-(4-Butoxyphenoxy)propyl]morpholine
| image = Pramoxine.svg

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|pramocaine}}
| MedlinePlus = a682429
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_UK = POM
| legal_US = 
| legal_CA = OTC 
| legal_status =  OTC, Rx only
| routes_of_administration = Topical, rectal, Vaginal

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 140-65-8
| CAS_supplemental = <br>{{CAS|637-58-1}} ([[hydrochloride|HCl]])
| ATC_prefix = D04
| ATC_suffix = AB07
| ATC_supplemental =   {{ATC|C05|AD07}}
| PubChem = 4886
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 4717
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 068X84E056
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 8357
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 1198

<!--Chemical data-->
| C=17 | H=27 | N=1 | O=3 
| molecular_weight = 293.401 g/mol
| smiles = O(c2ccc(OCCCN1CCOCC1)cc2)CCCC
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C17H27NO3/c1-2-3-12-20-16-5-7-17(8-6-16)21-13-4-9-18-10-14-19-15-11-18/h5-8H,2-4,9-15H2,1H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = DQKXQSGTHWVTAD-UHFFFAOYSA-N
}}
'''Pramocaine''' ([[International Nonproprietary Name|INN]] and [[British Approved Name|BAN]], also known as '''pramoxine''' or '''pramoxine HCI''') is a [[topical anesthetic]] discovered at Abbott Laboratories in 1953<ref name=":2">Schmidt JL, Blockus LE, Richards RK. The Pharmacology of Pramoxine Hydrochloride: A New Topical Local Anesthetic. Curr Res Anesth Analg. 1953 Nov-Dec;32(6:1):418-25.</ref> and used as an [[antipruritic]]. During research and development, pramocaine hydrochloride stood out among a series of alkoxy aryl alkamine ethers as an especially good topical local anesthetic agent.<ref name=":2" /> Pharmacologic study revealed it to be potent and of low acute and subacute toxicity, well tolerated by most mucous membranes and of a low sensitizing index in humans.<ref name=":2" /> Like other [[local anesthetics]], pramocaine decreases the permeability of neuronal membranes to sodium ions, blocking both initiation and conduction of nerve impulses. Depolarization and repolarization of excitable neural membranes is thus inhibited, leading to numbness.

== Use ==

Topical anesthetics are used to relieve pain and itching caused by conditions such as [[sunburn]] or other minor burns, insect bites or stings, [[poison ivy]], [[poison oak]], [[poison sumac]], and minor cuts and scratches.<ref>{{cite web|url=http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682429.html |title=Pramoxine |work=MedlinePlus Drug Information |publisher=National Library of Medicine |date=September 25, 2013 |accessdate=October 9, 2013}}</ref> The popular itch creams [[Gold Bond]] and some forms of [[calamine lotion]] use pramocaine [[hydrochloride]] to numb sensitive skin, as does the pain relief variant of [[Neosporin]] and some formulations of Sarna. The hydrochloride [[salt]] form of pramocaine is water-soluble.

Pramocaine and [[dibucaine]] are also common ingredients in [[Over-the-counter drug|over the counter]] [[hemorrhoid]] preparations.

== See also ==
* [[Local anesthesia]]

== Notes ==
{{Reflist}}


{{Vasoprotectives}}
{{Antipruritics}}

[[Category:Local anesthetics]]
[[Category:Morpholines]]
[[Category:Phenol ethers]]